Jeff Johnson
Stock Analyst at Robert W. Baird
(4.53)
# 1,025
Out of 4,534 analysts
609
Total ratings
51.2%
Success rate
10.3%
Average return
Main Sectors:
Stocks Rated by Jeff Johnson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INMD InMode | Maintained: Hold | $14 → $17 | $15.36 | +10.68% | 39 | Jul 14, 2026 | |
| COO The Cooper Companies | Maintained: Buy | $98 → $85 | $71.59 | +18.73% | 55 | Jun 5, 2026 | |
| ENOV Enovis | Maintained: Buy | $45 → $37 | $26.84 | +37.85% | 15 | May 8, 2026 | |
| PODD Insulet | Maintained: Buy | $360 → $248 | $167.37 | +48.17% | 45 | May 7, 2026 | |
| SWX: ALC Alcon Inc. | Maintained: Buy | CHF 76.75 → CHF 72.71 | CHF 56.76 | +28.10% | 33 | May 7, 2026 | |
| NVST Envista Holdings | Maintained: Buy | $30 → $31 | $26.58 | +16.63% | 37 | May 7, 2026 | |
| HSIC Henry Schein | Maintained: Buy | $104 → $97 | $86.20 | +12.53% | 56 | May 6, 2026 | |
| DXCM DexCom | Maintained: Buy | $87 → $80 | $75.69 | +5.69% | 60 | May 1, 2026 | |
| SYK Stryker | Maintained: Buy | $437 → $385 | $319.14 | +20.64% | 37 | May 1, 2026 | |
| ZBH Zimmer Biomet Holdings | Maintained: Hold | $100 → $92 | $89.72 | +2.54% | 37 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $12 → $14 | $13.46 | +4.01% | 53 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $28 → $14 | $17.82 | -21.44% | 7 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $205 → $218 | $175.05 | +24.54% | 66 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $18 → $30 | $18.10 | +65.75% | 60 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $43.77 | n/a | 1 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $67 | $4.57 | n/a | 1 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $42 → $49 | - | n/a | 6 | Dec 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $104.40 | n/a | 1 | Apr 11, 2016 |
InMode
Jul 14, 2026
Maintained: Hold
Price Target: $14 → $17
Current: $15.36
Upside: +10.68%
The Cooper Companies
Jun 5, 2026
Maintained: Buy
Price Target: $98 → $85
Current: $71.59
Upside: +18.73%
Enovis
May 8, 2026
Maintained: Buy
Price Target: $45 → $37
Current: $26.84
Upside: +37.85%
Insulet
May 7, 2026
Maintained: Buy
Price Target: $360 → $248
Current: $167.37
Upside: +48.17%
Alcon Inc.
May 7, 2026
Maintained: Buy
Price Target: CHF 76.75 → CHF 72.71
Current: CHF 56.76
Upside: +28.10%
Envista Holdings
May 7, 2026
Maintained: Buy
Price Target: $30 → $31
Current: $26.58
Upside: +16.63%
Henry Schein
May 6, 2026
Maintained: Buy
Price Target: $104 → $97
Current: $86.20
Upside: +12.53%
DexCom
May 1, 2026
Maintained: Buy
Price Target: $87 → $80
Current: $75.69
Upside: +5.69%
Stryker
May 1, 2026
Maintained: Buy
Price Target: $437 → $385
Current: $319.14
Upside: +20.64%
Zimmer Biomet Holdings
Apr 29, 2026
Maintained: Hold
Price Target: $100 → $92
Current: $89.72
Upside: +2.54%
Feb 27, 2026
Maintained: Hold
Price Target: $12 → $14
Current: $13.46
Upside: +4.01%
Feb 18, 2026
Maintained: Hold
Price Target: $28 → $14
Current: $17.82
Upside: -21.44%
Feb 5, 2026
Maintained: Buy
Price Target: $205 → $218
Current: $175.05
Upside: +24.54%
Dec 16, 2025
Upgraded: Buy
Price Target: $18 → $30
Current: $18.10
Upside: +65.75%
Dec 21, 2023
Reiterated: Buy
Price Target: n/a
Current: $43.77
Upside: n/a
May 5, 2023
Maintained: Buy
Price Target: $67
Current: $4.57
Upside: n/a
Dec 4, 2017
Reiterated: Hold
Price Target: $42 → $49
Current: -
Upside: n/a
Apr 11, 2016
Reiterated: Hold
Price Target: n/a
Current: $104.40
Upside: n/a